{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:08:08Z","timestamp":1778033288859,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00384-021-03952-4","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T08:02:59Z","timestamp":1621584179000},"page":"1905-1913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy: a real-world study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl","family":"Koski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"1","key":"3952_CR1","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.clcc.2018.10.002","volume":"18","author":"PM Kasi","year":"2019","unstructured":"Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18(1):e87\u2013e95","journal-title":"Clin Colorectal Cancer"},{"issue":"21","key":"3952_CR2","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1002\/cncr.32346","volume":"125","author":"CA Doubeni","year":"2019","unstructured":"Doubeni CA (2019) Early-onset colorectal cancer: what reported statistics can and cannot tell us and their implications. Cancer 125(21):3706\u20133708","journal-title":"Cancer"},{"issue":"1","key":"3952_CR3","doi-asserted-by":"publisher","first-page":"e1920407","DOI":"10.1001\/jamanetworkopen.2019.20407","volume":"3","author":"WH Abualkhair","year":"2020","unstructured":"Abualkhair WH, Zhou M, Ahnen D, Yu Q, Wu XC, Karlitz JJ (2020) Trends in incidence of early-onset colorectal cancer in the United States among those approaching screening age. JAMA Netw Open 3(1):e1920407","journal-title":"JAMA Netw Open"},{"key":"3952_CR4","doi-asserted-by":"publisher","first-page":"l5515","DOI":"10.1136\/bmj.l5515","volume":"367","author":"LM Helsingen","year":"2019","unstructured":"Helsingen LM, Vandvik PO, Jodal HC, Agoritsas T, Lytvyn L, Anderson JC et al (2019) Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ 367:l5515","journal-title":"BMJ"},{"issue":"21","key":"3952_CR5","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1002\/cncr.32347","volume":"125","author":"J Virostko","year":"2019","unstructured":"Virostko J, Capasso A, Yankeelov TE, Goodgame B (2019) Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004\u20132015. Cancer 125(21):3828\u20133835","journal-title":"Cancer"},{"issue":"21","key":"3952_CR6","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3748\/wjg.v25.i21.2565","volume":"25","author":"A Mannucci","year":"2019","unstructured":"Mannucci A, Zuppardo RA, Rosati R, Leo MD, Perea J, Cavestro GM (2019) Colorectal cancer screening from 45 years of age: thesis, antithesis and synthesis. World J Gastroenterol 25(21):2565\u20132580","journal-title":"World J Gastroenterol"},{"key":"3952_CR7","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.canep.2020.101828","volume":"69","author":"DE O'Sullivan","year":"2020","unstructured":"O\u2019Sullivan DE, Hilsden RJ, Ruan Y, Forbes N, Heitman SJ, Brenner DR (2020) The incidence of young-onset colorectal cancer in Canada continues to increase. Cancer Epidemiol 69:101828","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"3952_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1007\/s10147-019-01497-9","volume":"24","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. Int J Clin Oncol 24(12):1582\u20131587","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"3952_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1080\/17474124.2018.1495075","volume":"12","author":"A Giryes","year":"2018","unstructured":"Giryes A, Oweira H, Mannhart M, Abdel-Rahman O (2018) Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer: a patient-level pooled analysis of two clinical trials. Expert Rev Gastroenterol Hepatol 12(8):843\u2013848","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"3952_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4251\/wjgo.v12.i6.604","volume":"12","author":"A Batra","year":"2020","unstructured":"Batra A, Rigo R, Sheka D, Cheung WY (2020) Real-world evidence on adjuvant chemotherapy in older adults with stage II\/III colon cancer. World J Gastrointest Oncol 12(6):604\u2013618","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"3952_CR11","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.clcc.2020.05.005","volume":"19","author":"A Batra","year":"2020","unstructured":"Batra A, Kong S, Cheung WY (2020) Eligibility of real-world patients with stage II and III colon cancer for adjuvant chemotherapy trials. Clin Colorectal Cancer 19(4):e226\u2013e234","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"3952_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10549-019-05328-3","volume":"177","author":"Y Andersson","year":"2019","unstructured":"Andersson Y, Bergkvist L, Frisell J, de Boniface J (2019) Do clinical trials truly mirror their target population? an external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer. Breast Cancer Res Treat 177(2):469\u2013475","journal-title":"Breast Cancer Res Treat"},{"key":"3952_CR13","unstructured":"Surveillance & Reporting (2020)\u00a0Alberta cancer registry\/electronic medical records. cancer research & analytics, cancer care Alberta, Alberta health services"},{"issue":"10","key":"3952_CR14","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00384-019-03389-w","volume":"34","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O, Karachiwala H (2019) Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials. Int J Colorectal Dis 34(10):1741\u20131747","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"3952_CR15","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00384-019-03252-y","volume":"34","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O, Ahmed O (2019) Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer. Int J Colorectal Dis 34(4):675\u2013680","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"3952_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clcc.2018.12.006","volume":"18","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman O (2019) Impact of sex on chemotherapy toxicity and efficacy among patients with metastatic colorectal cancer: pooled analysis of 5 randomized trials. Clin Colorectal Cancer 18(2):110\u20135.e2","journal-title":"Clin Colorectal Cancer"},{"issue":"26","key":"3952_CR17","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1200\/JCO.2018.78.3290","volume":"36","author":"BC \u00d6zdemir","year":"2018","unstructured":"\u00d6zdemir BC, Csajka C, Dotto GP, Wagner AD (2018) Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology. J Clin Oncol 36(26):2680\u20132683","journal-title":"J Clin Oncol"},{"issue":"7","key":"3952_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1200\/JCO.20.02015","volume":"39","author":"K Absolom","year":"2021","unstructured":"Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P et al (2021) Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy. J Clin Oncol 39(7):734\u2013747","journal-title":"J Clin Oncol"},{"issue":"2","key":"3952_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2217\/cer-2020-0187","volume":"10","author":"O Abdel-Rahman","year":"2021","unstructured":"Abdel-Rahman O (2021) Patient-related barriers to some virtual healthcare services among cancer patients in the USA: a population-based study. J Comp Eff Res 10(2):119\u2013126","journal-title":"J Comp Eff Res"},{"issue":"3","key":"3952_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00520-014-2418-6","volume":"23","author":"HW Jung","year":"2015","unstructured":"Jung HW, Kim JW, Kim JY, Kim SW, Yang HK, Lee JW et al (2015) Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. Support Care Cancer 23(3):687\u2013694","journal-title":"Support Care Cancer"},{"issue":"15","key":"3952_CR21","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/jnci\/94.15.1160","volume":"94","author":"AD McCollum","year":"2002","unstructured":"McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson III AB et al (2002) Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 94(15):1160\u20131167","journal-title":"J Natl Cancer Inst"},{"key":"3952_CR22","unstructured":"https:\/\/www.albertahealthservices.ca\/assets\/info\/hp\/cancer\/if-hp-cancer-guide-gi004-early-stage-colon.pdf. Last accessed on 13\/2\/2021"},{"issue":"3","key":"3952_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.clcc.2013.04.004","volume":"12","author":"WY Cheung","year":"2013","unstructured":"Cheung WY, Shi Q, O\u2019Connell M, Cassidy J, Blanke CD, Kerr DJ et al (2013) The predictive and prognostic value of sex in early-stage colon cancer: a pooled analysis of 33,345 patients from the ACCENT database. Clin Colorectal Cancer 12(3):179\u2013187","journal-title":"Clin Colorectal Cancer"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-03952-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-021-03952-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-03952-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:55:57Z","timestamp":1744167357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-021-03952-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3952"],"URL":"https:\/\/doi.org\/10.1007\/s00384-021-03952-4","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"13 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by Health Research Ethics Board of Alberta (HREBA.CC-20\u20130215).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"O.A.: Advisory board with Eisai Canada and Roche Canada. PT: Advisory boards with Roche Canada, Eisai Canada, Teva, Pfizer, Novartis Canada, BMS, Merch, Astrazeneca Canada. SK: None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}